Owner Tissue Regeneration Therapeutics, Inc.

Inventors Davies, John Edward; Ennis, Jane Elizabeth; Turner, Jeffrey Donald

Agent Spruson & Ferguson

Pub. Number AU-A-2009240738

PCT Pub. Number WO2009/129616

Priority 61/046,630 21.04.08 US

Filing date 20 April 2009

Wipo publication date 29 October 2009

C07K 14/08 (2006.01) Peptides having more than 20 amino acids

A61K 35/44 (2006.01) Medicinal preparations containing material or reaction products thereof with undetermined constitution - Eyes

A61K 39/00 (2006.01) Medicinal preparations containing antigens or antibodies

A61K 48/00 (2006.01) Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases

A61P 31/00 (2006.01) Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

A61P 33/00 (2006.01) Antiparasitic agents

A61P 37/04 (2006.01) Drugs for immunological or allergic disorders

A61P 39/00 (2006.01) General protective or antinoxious agents

C07K 14/555 (2006.01) Peptides having more than 20 amino acids

C07K 16/10 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

C12N 5/10 (2006.01) Undifferentiated human, animal or plant cells, e.g. cell lines - Cells modified by introduction of foreign genetic material, e.g. virus-transformed cells

C12N 15/67 (2006.01) Mutation or genetic engineering - General methods for enhancing the expression

C12N 15/85 (2006.01) Mutation or genetic engineering - for animal cells